TSEM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tower Semiconductor Ltd (TSEM) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock is experiencing significant downward pressure, with a regular market drop of -9.03% and a pre-market decline of -5.56%. While the company has shown strong financial performance in Q4 2025 and analysts have raised price targets, the high P/E ratio of 64, hedge fund selling, and lack of positive trading signals suggest caution. The technical indicators also do not support an immediate entry point, and options data reflects a bearish sentiment. For now, it is better to hold off on purchasing this stock until the price stabilizes or more favorable conditions emerge.
The MACD is negative and expanding (-1.656), indicating bearish momentum. The RSI is at 27.996, suggesting oversold conditions but not yet signaling a reversal. Moving averages are converging, showing no clear trend. Key support lies at 109.667, which the stock is approaching, and resistance is at 115.749. Overall, the technical indicators suggest a bearish trend with no immediate buy signal.
Strong Q4 2025 financial performance, including a 14% YoY revenue increase and 45.33% YoY net income growth.
Analysts have raised price targets, with some projecting up to $180, citing strong growth in high-margin optical infrastructure products.
Significant hedge fund selling, with a 131.02% increase in selling activity last quarter.
G2 Investment Partners reduced its stake significantly, signaling reduced confidence.
High P/E ratio of 64, indicating overvaluation.
The stock is down significantly in regular and pre-market trading, reflecting bearish sentiment.
Tower Semiconductor reported record Q4 2025 revenue of $440 million, up 13.69% YoY. Net income increased by 45.33% YoY to $80.13 million, and EPS rose by 42.86% YoY to $0.7. Gross margin improved to 26.72%, up 19.13% YoY. The company is showing strong growth trends, particularly in high-margin optical infrastructure products.
Analysts have raised price targets significantly, with the highest being $180 (Susquehanna) and the lowest at $140 (Wedbush). Benchmark and Susquehanna maintain Buy ratings, while Wedbush and Barclays remain Neutral or Equal Weight. Analysts are optimistic about long-term growth but note that the stock's valuation already reflects much of the anticipated upside.
